| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2828 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2003-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9fcc09afc7a64a024a525688970f709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2662a6265e2ee3212b5aa002d7cfab5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d60a8545d31235853c80ae36a7401ff6 |
| publicationDate |
2004-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004171026-A1 |
| titleOfInvention |
Diagnostic method for transmissible spongiform encephalopathies |
| abstract |
Transmissible spongiform encephalopathy (TSE) is diagnosed in a subject by using mass spectrometry to observe a polypeptide in a sample of body fluid taken from the subject. The polypeptide is differentially contained in the body fluid of TSE-infected subjects and non-infected subjects, and has a molecular weight in the range of from 1000 to 100000. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10161941-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017254814-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10359431-B2 |
| priorityDate |
2001-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |